These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 37273690)

  • 1. Physiological and pathophysiological mechanisms of the molecular and cellular biology of angiogenesis and inflammation in moyamoya angiopathy and related vascular diseases.
    Dorschel KB; Wanebo JE
    Front Neurol; 2023; 14():661611. PubMed ID: 37273690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and Proteomic Contributions to the Pathophysiology of Moyamoya Angiopathy and Related Vascular Diseases.
    Dorschel KB; Wanebo JE
    Appl Clin Genet; 2021; 14():145-171. PubMed ID: 33776470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanobiological theory: a unifying hypothesis on the pathogenesis of moyamoya disease based on a systematic review.
    Sudhir BJ; Keelara AG; Venkat EH; Kazumata K; Sundararaman A
    Neurosurg Focus; 2021 Sep; 51(3):E6. PubMed ID: 34469862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteome Profiling of the Dura Mater in Patients with Moyamoya Angiopathy.
    Carrozzini T; Pollaci G; Gorla G; Potenza A; Rifino N; Acerbi F; Vetrano IG; Ferroli P; Bersano A; Gianazza E; Banfi C; Gatti L
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular Remodeling in Moyamoya Angiopathy: From Peripheral Blood Mononuclear Cells to Endothelial Cells.
    Tinelli F; Nava S; Arioli F; Bedini G; Scelzo E; Lisini D; Faragò G; Gioppo A; Ciceri EF; Acerbi F; Ferroli P; Vetrano IG; Esposito S; Saletti V; Pantaleoni C; Zibordi F; Nardocci N; Zedde ML; Pezzini A; Di Lazzaro V; Capone F; Dell'Acqua ML; Vajkoczy P; Tournier-Lasserve E; Parati EA; Bersano A; Gatti L
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32796702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase of Circulating Endothelial Progenitor Cells and Released Angiogenic Factors in Children with Moyamoya Arteriopathy.
    Gorla G; Carrozzini T; Pollaci G; Potenza A; Nava S; Acerbi F; Ferroli P; Esposito S; Saletti V; Ciusani E; Zulueta A; Parati EA; Bersano A; Gatti L; Vetrano IG
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Pathophysiology of Moyamoya Disease: An Update.
    Bang OY; Fujimura M; Kim SK
    J Stroke; 2016 Jan; 18(1):12-20. PubMed ID: 26846756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biallelic variants in NOS3 and GUCY1A3, the two major genes of the nitric oxide pathway, cause moyamoya cerebral angiopathy.
    Guey S; Hervé D; Kossorotoff M; Ha G; Aloui C; Bergametti F; Arnould M; Guenou H; Hadjadj J; Dubois Teklali F; Riant F; Balligand JL; Uzan G; Villoutreix BO; Tournier-Lasserve E
    Hum Genomics; 2023 Mar; 17(1):24. PubMed ID: 36941667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiological and clinical features of twig-like middle cerebral artery in comparison with moyamoya angiopathy: a multicenter retrospective study.
    Goto Y; Nanto M; Oka H; Murakami N; Nakagawa T; Kimura S; Iwamoto Y; Inoue Y; Matsumoto K; Miyamoto J; Hashimoto N
    J Neurosurg; 2022 Dec; 137(6):1718-1726. PubMed ID: 35426829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Management of Moyamoya Patients.
    Canavero I; Vetrano IG; Zedde M; Pascarella R; Gatti L; Acerbi F; Nava S; Ferroli P; Parati EA; Bersano A
    J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34441923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of Vascular Stenosis and Remodeling in Moyamoya Disease.
    Fox BM; Dorschel KB; Lawton MT; Wanebo JE
    Front Neurol; 2021; 12():661578. PubMed ID: 34539540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya.
    Miskinyte S; Butler MG; Hervé D; Sarret C; Nicolino M; Petralia JD; Bergametti F; Arnould M; Pham VN; Gore AV; Spengos K; Gazal S; Woimant F; Steinberg GK; Weinstein BM; Tournier-Lasserve E
    Am J Hum Genet; 2011 Jun; 88(6):718-728. PubMed ID: 21596366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of Moyamoya Angiopathy in Eastern India.
    Das S; Dubey S; Das S; Hazra A; Pandit A; Ghosh R; Ray BK
    Front Neurol; 2022; 13():837704. PubMed ID: 35309562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology and genetic factors in moyamoya disease.
    Achrol AS; Guzman R; Lee M; Steinberg GK
    Neurosurg Focus; 2009 Apr; 26(4):E4. PubMed ID: 19335130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limb-shaking TIA in Moyamoya angiopathy.
    Das S; Ghosh R; Dubey S; Pandit A; Ray BK; Kraemer M
    Clin Neurol Neurosurg; 2021 Aug; 207():106783. PubMed ID: 34225004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasculogenic and Angiogenic Pathways in Moyamoya Disease.
    Bedini G; Blecharz KG; Nava S; Vajkoczy P; Alessandri G; Ranieri M; Acerbi F; Ferroli P; Riva D; Esposito S; Pantaleoni C; Nardocci N; Zibordi F; Ciceri E; Parati EA; Bersano A
    Curr Med Chem; 2016; 23(4):315-45. PubMed ID: 26861126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Lipid Profiling Contributes to Untangle the Complexity of Moyamoya Arteriopathy.
    Dei Cas M; Carrozzini T; Pollaci G; Potenza A; Nava S; Canavero I; Tinelli F; Gorla G; Vetrano IG; Acerbi F; Ferroli P; Ciceri EF; Esposito S; Saletti V; Ciusani E; Zulueta A; Paroni R; Parati EA; Ghidoni R; Bersano A; Gatti L
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moyamoya disease and syndromes: from genetics to clinical management.
    Guey S; Tournier-Lasserve E; Hervé D; Kossorotoff M
    Appl Clin Genet; 2015; 8():49-68. PubMed ID: 25733922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Operative neurosurgery: personal view and historical backgrounds (9) Moyamoya angiopathy (MMA): past history and status presens].
    Yonekawa Y
    No Shinkei Geka; 2012 Jan; 40(1):67-87. PubMed ID: 22223526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.